相关实验视频
Updated: May 10, 2026
05:51
Characterization of a Novel Human Organotypic Retinal Culture Technique
Published on: June 9, 2021
3.8K
周围血液HIF-1α水平:关于它们对早期糖尿病视网膜病变的预测能力的研究
Endocrine connections
|April 11, 2025
概括
周围血液中的缺氧诱导因子-1α (HIF-1α) 水平在患有早期糖尿病视网膜病变 (DR) 的2型糖尿病患者中升高. 较高的HIF-1α表明DR风险增加,表明其作为早期检测生物标志物的潜力.
科学领域:
- 内分泌学 在内分泌学.
- 眼科医生 眼科 眼科
- 生物化学 生物化学
背景情况:
- 糖尿病视网膜病变 (DR) 是导致2型糖尿病 (T2D) 视力丧失的主要原因.
- 早期发现和预测DR风险对于及时干预至关重要.
- 缺氧诱导因子-1α (HIF-1α) 涉及到各种疾病过程,包括与糖尿病有关的疾病.
研究的目的:
- 研究2型糖尿病 (T2D) 患者中缺氧诱导因子-1α (HIF-1α) 和早期糖尿病视网膜病变 (DR) 的周围血液水平之间的相关性.
- 评估HIF-1α作为早期DR预测生物标志物的潜力.
主要方法:
- 在70名T2D患者 (25名T2D患者,45名DR患者) 和18名健康对照人群中测量了HIF-1α蛋白的血清水平.
- 根据 fundus 摄影结果对患者进行了分类.
- 进行了统计分析,包括斯皮尔曼相关性.
主要成果:
- 与T2D组相比,早期DR患者表现出明显更高的HIF-1α水平.
- HIF-1α与年龄,疾病持续时间,缩血压,肌素,禁食血葡萄糖 (FPG) 和糖化血红蛋白 (HbA1c) 有显著的正相关性.
- 在HIF-1α和HbA1c之间观察到强烈的正相关性,DR预测的最佳切断值为2.3855 ng/mL.
结论:
- 周围血液HIF-1α水平升高与T2D患者的DR发展有关.
- 作为糖尿病视网膜病变的早期检测和风险预测的潜在生物标志物,HIF-1α显示出希望.
相关概念视频
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...